-transparent.png){kind=logo}
Since its discovery in the 19th century, the complement system has developed into a clinically significant entity. The complement system has been implicated in a variety of clinical conditions, from autoimmune diseases to ischemia-reperfusion injury in transplantation. This article charts the historical progress of our understanding of the complement system and provides a synopsis on the activation pathways and its inherent regulators.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
P N Nesargikar, and
B Spiller, and
R Chavez
April 1972,
The New England journal of medicine,
P N Nesargikar, and
B Spiller, and
R Chavez
May 1979,
Nihon rinsho. Japanese journal of clinical medicine,
P N Nesargikar, and
B Spiller, and
R Chavez
November 2020,
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
P N Nesargikar, and
B Spiller, and
R Chavez
March 2018,
Oncotarget,
P N Nesargikar, and
B Spiller, and
R Chavez
September 2009,
Annals of the New York Academy of Sciences,
P N Nesargikar, and
B Spiller, and
R Chavez
November 2006,
The Journal of clinical investigation,
P N Nesargikar, and
B Spiller, and
R Chavez
January 2014,
Basic & clinical pharmacology & toxicology,
P N Nesargikar, and
B Spiller, and
R Chavez
November 2010,
Molecular cancer research : MCR,
P N Nesargikar, and
B Spiller, and
R Chavez
January 2018,
Clinical medicine insights. Arthritis and musculoskeletal disorders,
P N Nesargikar, and
B Spiller, and
R Chavez
October 1989,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
